SEC Form 4 · accession 0000914190-16-000518
Arno Therapeutics, Inc · ARNI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Tanen
Officer — Secretary · Director
Period of report
Jan 12, 2016
Accepted (ET)
Jan 14, 2016 · 5:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001195116
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 12, 2016 | P | 362,015 | $0.35 | A | 362,015 | I | By Trust |
| Common StockF3 | holding | — | — | — | 18,691 | I | By spouse for minor children | |
| Common Stock | holding | — | — | — | 171,712 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $8.00 | holding | — | — | — | — | Sep 29, 2019 | Common Stock | 1,250 | 1,250 | D |
| Stock Option (right to buy)F4 | $8.00 | holding | — | — | — | — | Nov 5, 2020 | Common Stock | 1,250 | 1,250 | D |
| Stock Option (right to buy)F5 | $2.40 | holding | — | — | — | — | Nov 4, 2023 | Common Stock | 68,448 | 68,448 | D |
| Stock Option (right to buy)F6 | $2.90 | holding | — | — | — | — | Jan 24, 2024 | Common Stock | 34,224 | 34,224 | D |
Explanation of responses
- F1On January 12, 2016, the David M. Tanen Revocable Grantor Trust was issued 362,015 shares upon the automatic conversion of $126,705.48 of principal and accrued interest under a 6% unsecured convertible promissory note previously issued to the David M. Tanen Revocable Grantor Trust by the Issuer on October 21, 2015.
- F2Held by the David M. Tanen Revocable Grantor Trust, of which the Reporting Person is a beneficiary.
- F3Held by the Reporting Person's spouse as custodian for the benefit of their minor children under the Uniform Gift to Minors Act. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.
- F4Currently exercisable.
- F5Vests in equal 36-monthly installments commencing 12/4/13.
- F6Vests in equal 12-monthly installments commencing 2/24/14.